• About Us
    • Our Company
    • Management Team
    • Board of Directors
    • Clinical Advisory Board
  • Product Candidates
  • Recent News
    • Press Releases
    • Research + Whitepapers
    • News
  • Contact Us
The AI Paradigm Shift: How Cutting-Edge Tech is Fast-Tracking the Future of Medicine

The AI Paradigm Shift: How Cutting-Edge Tech is Fast-Tracking the Future of Medicine

by Dr. Josep Bassaganya-Riera | Sep 10, 2024 | Press Release

An original version of this article appeared in the Pharmaceutical Executive. The AI revolution is shaping numerous facets of our lives. While advancements by OpenAI and Anthropic plus NVIDIA’s market performance have commanded a significant portion of media...

Recent Posts

  • The NIMML Institute and NImmune Biopharma Announce Publication of New Mechanistic Insights on the Immunometabolic Control of Systemic Lupus Erythematosus in the Journal of Immunology
  • NImmune Biopharma to Participate in UBS Virtual Biotechnology Private Company
  • The AI Paradigm Shift: How Cutting-Edge Tech is Fast-Tracking the Future of Medicine
  • NImmune Biopharma Announces R&D Collaboration with BioTherapeutics, Inc. to Advance the Next Wave of Inflammation and Immunology Precision Medicines
  • NImmune Biopharma Presents Positive First-in-Human Data of NIM-1324, a Phase 2 Candidate for Systemic Lupus Erythematosus at the American College of Rheumatology Convergence 2023 (#ACR23)

Recent Comments

No comments to show.
  • About Us
  • Management Team
  • Board of Directors
  • Clinical Advisory Board
  • Product Candidates
  • Contact Us

Copyright © 2023 NImmune Biopharma